BioMarin Pharmaceutical, Inc. (BMRN)
56.17
-1.01
(-1.77%)
USD |
NASDAQ |
Jan 23, 16:00
56.75
+0.58
(+1.03%)
After-Hours: 18:31
BioMarin Pharmaceutical Price: 56.17 for Jan. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.28 |
| Gilead Sciences, Inc. | 135.73 |
| Merck & Co., Inc. | 108.17 |
| AbbVie, Inc. | 219.25 |
| Biogen, Inc. | 171.56 |
Price Related Metrics
| PE Ratio | 21.05 |
| PS Ratio | 3.560 |
| PEG Ratio | 0.3467 |
| Price to Book Value | 1.782 |
| Price to Free Cash Flow | 13.30 |
| Earnings Yield | 4.75% |
| Market Cap | 10.79B |
| PEGY Ratio | 0.3467 |
| Operating PE Ratio | 12.84 |
| Normalized PE Ratio | 15.74 |